Muscular dystrophies encompass a family of progressive genetic disorders affecting muscle strength and integrity.
Muscular dystrophies encompass a family of progressive genetic disorders affecting muscle strength and integrity. Stem-cell research investigates whether placental mesenchymal stem cells (MSCs) and fetal stem cells can integrate into damaged muscle tissue, secrete anti-inflammatory factors, and halt the cascade of degeneration characteristic of conditions like Duchenne muscular dystrophy. The approach targets both direct muscle regeneration through cell fusion and paracrine effects that reduce inflammation and fibrosis. With 26 registered trials and 4 currently recruiting participants, early-phase data suggests MSCs may slow progression, particularly when infused systemically or injected locally into affected muscles. The neuromuscular pathology — characterised by dystrophin loss and calcium dysregulation — creates a uniquely hostile environment for transplanted cells, making efficacy variable and recovery timescales extended.
| עלות מעריכה · בולגריה (EU) | €3,000–€8,000 |
|---|---|
| טווח עלויות השוק הגלובלי | €15,000–€30,000 (bioinformant.com) |
| סוגי התאים העיקריים שנחקרו | MSCs from Amniotic Membrane, Fetal Stem Cells |
| סטטוס אישור | ניסיוני |
| ניסויים רשומים (ClinicalTrials.gov) | 26 · 4 recruiting now |
For the clinic's own description, see how Stem Plus describes its Muscular Dystrophy programme ↗.
Clinical trials in muscular dystrophy have predominantly featured small cohorts and observational designs. Four recruiting studies suggest ongoing clinical investigation, though definitive efficacy data remain limited. Some trials reported modest improvements in muscle strength measures and reduced serum creatine kinase levels following MSC infusion, whilst others showed minimal functional benefit. The heterogeneity of dystrophy subtypes means outcomes differ markedly between Duchenne, Becker, and limb-girdle forms. Current evidence supports MSCs as a potential supportive therapy rather than curative, with strongest signals emerging from early-intervention cohorts. Long-term safety data are sparse, and disease progression often continues despite treatment.
Depending on assessment, a Muscular Dystrophy protocol may draw on:
Muscular dystrophy treatment costs typically range €4,000–7,500 per cycle, reflecting the need for multiple infusions and specialist neuromuscular assessment. Placental MSC sourcing and expansion for systemic administration incurs higher manufacturing expense than single-injection protocols. Disease severity and muscle group involvement influence whether local or systemic delivery is elected, affecting total cost. Many programmes require baseline and follow-up neuroimaging and strength testing, adding to overall expenses. European centres generally charge at the lower end of the range for research-protocol participation, whilst private clinics may exceed €8,000 per session.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Muscular Dystrophy cost-by-country breakdown, or compare the best countries for Muscular Dystrophy →
Before booking, check safety & regulation, the recovery climate, אם אתה עשוי להיות מועמד, and which cell type fits Muscular Dystrophy.
שאלות תשובות דיסטרופיה שרירית מלאות → · פירוט עלויות דיסטרופיה שרירית →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: האם אני מועמד? · איזה סוג תאים? · Types of clinics & best countries · מחשבון עלויות
בדוקה רפואית על ידי צוות העריכה של StemCellAtlas עם Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) של קליניקת השותף Stem Plus (סופיה), כנגד הנחיות ISSCR, FDA ו-EMA. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם